![](/img/cover-not-exists.png)
The quality and characteristics of clinical drug study notifications reviewed by the regulatory agency in Finland
Tuija Keinonen, M.Sc.Pharm, Sakari Nieminen, Virpi Saareks, Pirkko Miettinen, Veijo Saano, Pauli YlitaloVolume:
23
Year:
2002
Language:
english
Pages:
10
DOI:
10.1016/s0197-2456(01)00181-7
File:
PDF, 90 KB
english, 2002